Upload
hakhanh
View
221
Download
1
Embed Size (px)
Citation preview
Publications
Anatomical Pathology
Biochemistry
Genetics and Molecular Pathology
Haematology
Microbiology
An
ato
mic
al P
ath
olo
gy
Alamgeer M, Ganju V, Szczepny A, Russell PA, Prodanovic Z, Kumar Beena, Wainer Z, Brown
T, Schneider-Kolsky M, Conron M, Wright G, Watkins DN. The prognostic significance of
aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-small
cell lung cancer. Thorax. 2013 Aug 7
Muhammad Alamgeer, Vinod Ganju, Beena Kumar, Jane Fox, Stewart Hart, Michelle White,
Marion Harris, John Stuckey, Zdenka Prodanovic, Michal E Schneider and D Neil Watkins.
Changes in ALDEHYDE DEHYDROGENASE-1 (ALDH1) expression during neoadjuvant
chemotherapy predict outcome in locally advanced breast cancer. Breast Cancer Research.
Breast Cancer Res. 2014; 16(2): R44
- Chian A. Chang, Beena Kumar, and Deepali Nandurkar. A Case Report of High 18F-FDG
PET/CT Uptake in Progressive Transformation of the Germinal Centers. Medicine. CLINICAL
CASE REPORT Medicine 94(23):e412).
- Naseem Mirbagheri · Beena Kumar · Siddhartha Deb · Benjamin R Poh · Jonathan G Dark ·
Christopher C Leow William M K Teoh. Lymph node status as a prognostic indicator after
preoperative neoadjuvant chemoradiotherapy of rectal cancer. Colorectal Disease
06/2014; 16(10). DOI:10.1111/codi.12682
Treatment of chronic antibody mediated rejection with a protocol including a single fixed
low-dose of Ritxumab. PI: Dr W Mulley.
Signalling pathways in antibody mediated renal allograft rejection. PI: Dr William Mulley.
Evaluation of oncogenic signalling pathways in resected glioblastoma samples at initial
diagnosis and recurrence. PI: Dr J Lickliter.
The correlation between pre-operative evaluation of regional neck disease with Positive
Emission Topography and histopathological specimens in head and neck squamous cell
carcinoma. PI: Ms E Sigston.
Bio
che
mis
try Lu ZX, Walker KZ, O’Dea K, Sikaris KA & Shaw JE. HbA1c for screening and diagnosis of Type 2
diabetes in routine clinical practice. Diabetes Care 2010; 33:817–819
Gagnon C. Lu ZX. Magliano DJ. Dunstan DW. Shaw JE. Zimmet PZ. Sikaris K. Grantham N. Ebeling
PR. Daly RM. Serum 25-hydroxyvitamin D, calcium intake, and risk of type 2 diabetes after 5
years: results from a national, population-based prospective study (the Australian Diabetes,
Obesity and Lifestyle study). Diabetes Care. 2011; 34(5):1133-8.
Huynh J, Lu T, Liew D, Doery JCG, Tudball R, Jona M, Bhamshee R, Rodda C The VINE study. An
RCT comparing daily and bolus supplementation in breastfed infants of vitamin D deficient
mothers Submitted (NEJM June 2015) Lancet August 2015
Lee MKV, Vasikaran S, Doery JCG, Wijeratne N, , Prentice D. Cortisol:ACTH ratio for screening for
primary hypoadrenalism: A pilot study Postgrad Med J 2013;89:617-620
Fedele PL, Choy KW, Doery JCG, Grigoriadis G, Shortt J, Lu ZX Inter-laboratory discordance of
beta-2 microglobulin results: impact on the validity of the international staging system for
multiple myeloma Brit J Haemat2014;166:951-953
The Role of Adrenal Vein Sampling in Primary Aldosteronism: the Monash Health Experience Int
Med J Accepted August 2015
Yen T, Cowley D, Doery JCG, Haworth E, Lewis B, McKay R, Metz M, Mottram B, Coakley J The
AACB workshop on harmonised reference limits – Recommendations for pediatric reference
intervals Clin Biochem Rev 2012; 33; Suppl S39
Teng J, Hutchinson ME, Chee NYN, Doery JCG, Choy KW, Chong W, Fuller PJ, Yang J Effect of
adrenocorticotropic hormone stimulation on the outcomes of adrenal vein sampling in primary
aldosteronism Endocrine Society of Australia ASM 2015
Ge
ne
tics
an
d M
ole
cula
r P
ath
olo
gy Eggermann T, Brioude F, Russo S, Lombardi M, Bliek J, Maher E, Larizza L, Prawitt D, Netchine I,
Gonzales M, Gronskov K, Tümer Z, Monk D, Mannens M, Chrzanowska K, Krajewska-Walasek M,
Begemann M, Soellner L Eggermann K, Nevado J, Moore G, Mackay D, Temple K, Gillessen-
Kaesbach G, Ogata T, Weksberg R, Algar E, and Lapunzina P. 2015.Prenatal molecular testing for
Beckwith-Wiedemann and Silver-Russell syndromes: A challenge for molecular analysis and
genetic counseling Paper #544-15-EJHGR. In press.
Heath J, Smibert E, Algar E.M, Dite G.S, Hopper J. (2014). Cancer risk for relatives of children with
cancer. J Cancer Epidemiol. 2014:806076. doi: 10.1155/2014/806076. Epub 2014 Mar 27.
Eggermann T, Algar E, Lapunzina P, Mackay D, Maher ER, Mannens M, Netchine I, Prawitt D, Riccio
A, Temple IK, Weksberg R. 2013 Clinical utility gene card for: Beckwith-Wiedemann syndrome.
Eur J. Hum Genet. doi: 10.1038/ejhg.2013.132. Epub 2013 Jul 3.
Bandopadhayay P, Jabbour AM, Riffkin C, Salmanidis M, Gordon L, Popovski D, Rigby L, Ashley DM,
Watkins DN, Thomas DM, Algar E, Ekert PG.(2013). The oncogenic properties of EWS/WT1 of
desmoplastic small round cell tumors are unmasked by loss of p53 in murine embryonic
fibroblasts. BMC Cancer. Dec 9;13:585. doi: 10.1186/1471-2407-13-585.
Birks DK, Donson AM, Patel PR, Sufit A, Algar EM, Dunham C, Kleinschmidt-Demasters BK, Handler
MH, Vibhakar R, Foreman NK. 2013. Pediatric rhabdoid tumors of kidney and brain show many
differences in gene expression but share dysregulation of cell cycle and epigenetic effector
genes. Pediatr Blood Cancer. Feb 4. doi: 10.1002/pbc.24481.
Hu M, Fletcher J, McCahon E, Catchpoole D, Zhang GY, Wang YM, Algar EM, Alexander SI. Bilateral
Wilms Tumor and Early Presentation in Pediatric Patients Is Associated with the Truncation of
the Wilms Tumor 1 Protein J Pediatr. 2013. Feb 9. doi:pii: S0022-3476(12)01569-7.
10.1016/j.jpeds.2012.12.080.
Daniel E. Sabbath, Elizabeth M. Algar,, Pritish K. Bhattacharyya, Karen E. Bijwaard, Tao Hong, Neal
Lindeman, Rajyalakshmi Luthra Richard D. Press, Paul G. Rothberg, Rana Domiati Saad, Zeba N.
Singh, Emily S. Winn-Deen. 2012. Nucleic Acid Amplification Assays for Molecular
Hematopathology; Approved Guideline Second Edition MM05-A2 CLSI Vol 32, No 6.
Lin Rigby, Andrea Muscat, David Ashley and Elizabeth Algar. (2012). Methods for the detection of
histone acetylation in blood. Epigenetics.7:8, 1-8.
Nicholas C. Wong, David Ashley, Zac Chatterton, Mandy Parkinson-Bates, Hong Kiat Ng, Minhee S.
Halemba, Adam Kowalcyk, Justin Bedo, Qiao Wang, Katrina Bell, Elizabeth Algar, Jeff Craig and
Richard Saffery. (2012) A distinct DNA methylation signature defines paediatric pre-B cell acute
lymphoblastic leukaemia. Epigenetics, Jun 1 Volume 7 (6) pp 535-541.
Elizabeth Algar, Andrea Muscat, Vinod Dagar, Christian Rickert, CW Chow, Jacqueline Biegel, Paul
Ekert, Ricky Johnstone and David Ashley. (2009). Imprinted CDKN1C is activated by histone
deacetylase inhibitors and restoration of SMARCB1 in rhabdoid tumor. PLoS ONE 4(2): e4482.
doi:10.1371/journal.pone.0004482.
Tomasz K. Wojdacz, Alexander Dobrovic and Elizabeth M. Algar. (2008) Rapid detection of
methylation change at H19 in human imprinting disorders using methylation sensitive high
resolution melting. Human Mutation Vol. 29, p1255-1260.
Meredith Wilson, Gregory Peters, Bruce Bennetts, George McGillivray, Zan He Wu, Christopher
Poon, Elizabeth Algar. (2008). The Clinical Phenotype of Mosaicism for Genome-wide Paternal
Uniparental Disomy: Two New Reports. American J. Med Genetics. Part A. Vol. 146A p137-
148.
Meyepa L, Globin chain separation for alpha/beta thal diagnosis on HPLC, poster
presentation, HSA New Zealand, 1997
Swain M, Reticulocyte performance on the Cell Dyn 3500, poster presentation, AIMS
Perth, 1997
Howells S, Hypercoaguable screen for DVT patients - when should they be performed,
poster presentation, AIMS Perth, 1997
Wheeler M, RCPA - QA and educational broadsheet on Protein C and Protein S, poster
presentation, HAS Sydney, 1998
Wheeler M, Evaluation of a portable monitor for INR determinations (OP and HIH
evaluation of the CoaguCheck), poster presentation, ISTH Washington, 1999
Murphy B, Positive lupus anticoagulant tests and thrombotic risk (A comparison of
different methods in 500 requests - aptt, tti, rvv, Auto kct), poster presentation, ASBT
Melbourne, 1999
Snooks J, Current trends in usage of autologous blood (a comparison of today’s data c/w
that of 5 years ago), poster presentation, ASBT Melbourne, 1999
Wheeler M, New Technologies in the Coagulation Laboratory, Invited speaker, AIMS
Sydney, 2000
Wheeler M, Near Patient Testing for oral Anticoagulation Monitoring, Invited speaker,
AIMS
Sydney, 2000
Meyepa L, Detection of the PT20210A mutation using allele specific PCR, poster
presentation, HAS Perth, 2000
Swain M, An automated Ddimer assay, adapted for the IL futura (c/w dimertest latex and
nycocard), poster presentation, AIMS Sydney, 2000
Turner C, Life threatening haemolytic transfusion reaction in haemoglobinopathy patients,
poster presentation, HAS Perth, 2000
Erica Malan Prevalence of positive thrombophilic markers in DVT patients, poster
presentation, HSA Perth, 2000
Allwright J, Evaluation of transfusion protocol for T activated neonates, poster
presentation, AABB
Washington, 2000
Butler J, Assessment of the PFA-100 in cardiopulmonary bypass surgery, poster
presentation, ISTH Paris, 2001
Butler J, Evaluation of the PFA-100 in a busy routine laboratory for diagnosis of platelet
dysfunction and its utility in the monitoring of DDAVP response before surgery, poster
Hae
mat
olo
gy
presentation, ISTH Paris, 2001
Wheeler M, Evaluation of near patient testing using portable INR monitors in an
anticoagulant clinic (CoaguChek and Protime), poster presentation, HSA Brisbane, 2001
Malan E, LMW Heparin monitoring during IVF pregnancy, poster presentation, HSA
Brisbane, 2001
McPhee G, Polyethylene glycol (PEG) enhanced adsorption to isolate alloantibodies with
free autoantibodies: a two year experience of a routine blood bank laboratory, poster
presentation, HSA Brisbane, 2001
Bennett V, A performance evaluation of the Abbott Cell Dyn 3700, poster presentation,
AIMS Melbourne, 2001
Jaskolowski S, Wheeler M, An evaluation of the Coulter LH750, invited speaker, Beckman
Coulter Victorian launch, Melbourne, 2002
Wheeler M, Jaskolowski S, An evaluation of the Coulter LH750, invited speaker, Beckman
Coulter NZ users group meeting, Auckland, 2002
Jaskolowski S, Choong S, Malan E, Wheeler M, Gan T, Opat S, Anticoagulant control in a
specialist haemostasis clinic with point of care testing - an 18 month review, HSANZ/ASBT
National meeting, Adelaide, 2002
Weinhandl JA, Allwright JE, Gan TE, Using pretransfusion samples collected more than 72
hours before transfusion. Is it safe?, HSANZ/ASBT National Meeting, Adelaide, 2002
Butler J, HITTS, Lepuridin and bypass surgery - a successful outcome, invited speaker,
National HITTS Meeting, Sydney, 2003
Butler J, Coagulation and the bleeding patient, Invited speaker, HDG/VIDG Meeting, 2003
Allwright J, Prophylactic anti D, Invited speaker, VIDG/HDG Meeting, 2003
Wheeler M, Malan E, Gan TE, et al, A prospective multicentre study assessing the random
error rates of routine coagulation tests, poster presentation, ISTH Birmingham, 2003
Tran H, Wheeler M, Gan TE, A pilot study - efficacy of low dose warfarin with PF12
monitoring in high risk VTE patients, poster presentation, ISTH Birmingham, 2003
Favaloro E, Wheeler M, et al, Laboratory diagnosis of congenital thrombophilia: current and
past practice in Australia, poster presentation, ISTH, Birmingham, 2003
Bennett V, Wheeler M, Opat S, Neonatal morphology - a retrospective review at Monash
Medical Centre, poster presentation, AIMS NSM, Gold Coast, 2003
Rushford K, Meyepa L, Butler J, Wheeler M, Gan T, Opat S, Testing for Factor V Leiden by a
functional clotting method and a genetic test : experience of a hospital referral laboratory,
poster presentation, AIMS NSM, Gold Coast, 2003
Rushford K, Meyepa L, Wheeler M, Gan T, Opat S, Hyperhomocysteinaemia and the MTHFR
genetic abnormality, poster presentation, AIMS NSM, Gold Coast, 2003
Kenealy M, Butler J, Opat S, Control of cerebral haemorrhage with recombinant factor VIIa
in a patient overanticoagulated with LMWH, poster presentation, HSANZ, Christchurch,
2003
Gan TE, Wheeler M, Malan E, Goergen S, et al, A prospective study assessing the clinical
utility of Ddimer levels and a clinical risk assessment model for the exclusion of pulmonary
embolism, prize winning poster presentation, HSANZ, Christchurch, 2003
Meyepa L, Gan TE, Bowden D, Opat S, Investigation of rare haemoglobin variants, poster
presentation, HSANZ, Christchurch, 2003
Favaloro E, Wheeler M, et al, Laboratory diagnosis of congenital thrombophilia: current and
past practice in Australia, poster presentation, HSANZ, Christchurch, 2003
Butler J, Malan E, Gan TE, HITTS, Lepirudin, Bypass surgery – a successful outcome, Invited
speaker, National HITTS school, Sydney, 2003
Grey D, Allwright J, et al, Haemolytic disease of the newborn caused by a new kell antigen,
prize winning poster presentation, BBTS, Manchester, 2003
Haywood J, A new Kell blood group, invited speaker, AIMS Vic branch weekend conference,
Castelmaine, 2004
Goergen S, Gan TE, Wheeler M, et al, Reducing the use of diagnostic imaging in patients
with suspected PE: validation of a risk strategy, publication submitted to Annals of
Emergency Medicine, 2004
Gan T.E, Butler.J, Malan.E, .Lepirudin in Coronary Artery Bypass Surgery – the local
experience, poster Fibrinolysis conference, Melbourne 2004
Manikappa.S. Benfield.K., Gan TE, Butler.J., Malan. E, Heparin-induced thrombocytopenia
and use of r-hirudin during CPB, Publication submitted to Anaesthesia and Intensive Care.
2004
Peverill.R. Gan.TE, Malan.E., Teede, et al, .Effect of hormone therapy on VWF in post-
menopausal women. –submitted as letter to Editor to Journal of Thrombosis and
Haemostasis. 2004
Peverill.R., Smolich.J., Malan.E. – Comparison of effects of Pravastatin and hormone therapy
on S.P-selectin and platelet P-selectin expression in post-menopausal hypercholesterolemic
women submitted for publication to Cardiology. 2004
Teede.H., Dalais.F., Kotopoulos .D., McGrath.B., Malan.E.,Gan.T.E.,Peverill.R Dietary soy-
containing phytoestrogens does not activate the haemostatic system in post-menopausal
women –submitted for publication to Journal of Clinical Endrocrinol. Metab. 2004
Favaloro E, Wheeler M, et al, Multi laboratory testing of thrombophilia: current and past
practice in Australasia as assessed through the RCPA QA program for haematology, Semin
Th Haemost, 31(1) Feb 2005
Favaloro E, Wheeler M, et al An international survey of current practice in the laboratory
assessment of anticoagulation therapy with heparin, Pathology 37(3) June 2005
Wheeler M, Automation in a large laboratory, Invited speaker, Tasmanian Annual Scientific
meeting, Bridport, 2005
Wheeler M, Point of care testing, Invited speaker, Tasmanian Annual Scientific meeting,
Bridport, 2005
McPhee G, Allwright J, Wheeler M, Screening for Feto-maternal Haemorrhage using Acid
Elution Techniques, Poster presentation HSANZ /ASBT conference, Sydney, 2005
Viedra K, Zhong L, Wheeler M, Gan E, et al, Evaluation of Transferrin Receptor / Ferritin
Ratio in the Diagnosis of Iron Deficiency in Patients with other Medical Conditions – A Pilot
Study, Poster presentation HSANZ / ASBT conference, Sydney, 2005
Wheeler M, Butler J, Malan E, Gan T, An evaluation of the ACL TOP Coagulation
Autoanalyser, Poster presentation ISTH conference, Sydney, 2005
Malan E, Butler J, Gan T, The development of a protocol for Lepirudin Therapy Monitoring,
Poster presentation ISTH conference, Sydney, 2005
Butler J, Malan E, Gan T, Evaluation of diamed HPIA.... HITTS, Poster presentation ISTH
conference, Sydney, 2005
Favaloro E, Wheeler M, et al, How useful is the monitoring of (Low Molecular Weight)
Heparin Therapy by Anti-Xa Assay? A Laboratory Perspective, Lab Haem, 2005, 11:157-162
Meyepa L, Bowden D, Wheeler M, Gan TE. Raised HbF investigation in a haemoglobinopathy
screening program. Poster presentation, HSANZ National Scientific Meeting, Hobart, 2006.
Baker S, Wheeler M, Gan TE. Ultracentrifugation is acceptable for rapid routine coagulation
testing. Poster presentation, HSANZ National Scientific Meeting, Hobart, 2006.
Baker S, Wheeler M, Lewis A, Gan TE. The haematocrit test for neonatal patients – a
comparison of methods. Poster presentation, HSANZ National Scientific Meeting, Hobart,
2006.
Wheeler M. Automated coagulation analysers – initial evaluation and ongoing operation.
Invited speaker, AIMS National Scientific Meeting, Hobart, 2006.
Wheeler M. Point of care monitors and warfarin therapy control. Invited speaker, AIMS
National Scientific Meeting, Hobart, 2006.
Allwright J, Gen TE. Post transfusion hyperhaemolysis syndrome in sickle cell disease. Poster
presentation, ASBT National Scientific Meeting, Hobart, 2006.
Bennett V, Wheeler M, Lewis A, Gan TE. The full blood count and morphology results in
neonatal bacteremic septicaemia – a 12 month retrospective study. Poster presentation,
AIMS National Scientific Meeting, Hobart, 2006.
Peverill R, Malan E, et al. Comparison of effect of prarastatin and hormone therapy on Sol P-
Selectin and platelet P-Selectin expression. Maturitas, 2006, 53(2), 158-165
Clifford J, Meyepa L, Opat S, et al. Haemoglobin Rothschild presenting with low peripheral
oxygen saturation by pulse oximetry: A case report. Poster presentation, HSANZ National
Scientific meeting, Gold Coast, 2007
Trimnell T, Allwright J, Gan TE, et al. The clinical significance of Anti-M in pregnancy. Poster
presentation, HSANZ National Scientific meeting, Gold Coast, 2007
Butler J, Wheeler M, Malan E, Gan TE. A potential source of erroneous results on
coagulation analysers – an observational study. Poster presentation, ISTH international
scientific meeting, Geneva, 2007
Peverill R, Malan E, et al. Relationship of waist hip circumference with coagulation and
fibrinolysis in postmenopausal women, Clin Sci, 2007, 113, 383-390
Malan E et al, Evaluation of an ADAMTS13 Activity ELISA assay for routine use, Poster
presentation, ANZSBT National Scientific meeting, Perth, 2008
Malan E et al, Current status of INR point-of-care testing, , Invited speaker, ASTH national
workshop, Perth, 2008
Butler J, TTP, vWF and ADAMTS13, Invited speaker, AIMS National Scientific meeting,
Melbourne, 2008
Meyepa L, Haemoglobinopathy case studies, Invited speaker, AIMS National Scientific
meeting, Melbourne, 2008
Wheeler M, Error rates on Coagulation analysers, Invited speaker, Beckman Coulter User
group, Melbourne, 2008
Butler J, ACL curve analysis, Invited speaker, Beckman Coulter User group, Melbourne, 2008
Fitzmaurice A, Malan E, Butler J, Wheeler M, Tran H, Laboratory monitoring of oral
anticoagulant patients with lupus anticoagulant, Poster presentation HSANZ, Adelaide, 2009
Wheeler M, Qayum S, Jaskolowski S, An evaluation of the DxH800 automated cell counter,
Poster presentation AIMS national scientific meeting Adelaide, 2009,
Wheeler M, Qayum S, Jaskolowski S, An evaluation of the DxH800 automated cell counter,
Poster presentation Beckman national user group meeting, 2009,
Jaskolowski S, Wheeler M, Qayum S, An evaluation of the DxH800 automated cell counter,
Oral presentation Beckman national user group meeting, 2009,
Malan E, Factor VIII assay dilemas, Oral presentation Beckman national user group
meeting2009,
Butler J, Malan E, Clifford J, Wheeler M, Gan E, Evaluation of an ADAMTS13 activity ELISA
assay, Poster presentation ISTH, Boston, 2009
Hoskin E, Meyepa L, Wheeler M, Guirguis A, An evaluation of the Sebia Minicap capillary
electrophoresis analyser, Poster presentation AIMS national scientific meeting Adelaide,
2009,
Putrino A, Allwright J, Wheeler M, Comparison of antenatal antibody titres by automated
analyser and manual technique, Poster presentation, HSANZ, Adelaide, 2009,
Guirguis A, Malan E, Butler J, Wheeler M, LA testing sensitivity specificity, Poster
presentation, HSANZ, Adelaide 2009
Kaplan Z, Butler J Malan E, LA testing is uninterpretable in patients receiving Rivaroxaban
therapy for VTE, Eur Haem Assoc international scientific meeting, Barcelona2009
Merriman E, Kaplan Z, Butler J, Malan E, Gan E, Tran H ‘Rivaroxaban and false positive lupus
anticoagulant testing, Thromb Haemost, 2011, 105:2, 385-386
Wheeler M et al, Evaluation of a new automated immunological white cell differential,
Poster presentation, AIMS, Gold Coast2011,
Rushford K et al, Serological results in patients with autoantibodies – A single institution
retrospective audit, Poster presentation, ANZSBT, Sydney, 2011
Rushford K et al, Issues in the serial titration of clinically significant antibodies in an
antenatal patient, Poster presentation, ANZSBT, Sydney2011
Malan E, Evaluation of the HemosIL HIT test c/w established methods in the diagnosis of
HITTS, Poster presentation, HSA, Sydney2011
Rushford K, A single institution audit of transfusion practice and wastage of paediatric
packs of red cells, Oral presentation, NICE, Albury2011,
Hosken R, A national audit of titration of antenatal antibodies, Oral presentation, NICE,
Sydney, 2011
Wheeler M, Evaluation of a new automated immunological white cell differential, Poster
presentation, BCUG, Melbourne2011,
Rushford K, Rh(D) Immunoglobulin Therapy in the Treatment of Immune
Thrombocytopenic Purpura. Oral Presentation, NICE, Albury 2012,
Rushford K et al, Case Report of a Haemolytic Transfusion Reaction Due to anti-Colton(b),
Poster Presentation, HAA, Melbourne. 2012,
Rushford K, Hoskin E, et al, Frequency of Anti-Mia Antibodies in the Patient Population of a
Tertiary Hospital, Poster Presentation, HAA, Melbourne. 2012,
Rushford K, et al, Anaemia in Surgical Patients Attending a Preoperative Anaesthetic
Assessment Clinic, , Oral Presentation, HAA, Melbourne. 2012
Rushford K, et al, Albumin Traceability - Lesson Learnt from the Albuminex Recall, 2012,
Oral Presentation, HAA, Melbourne. 2012
Wheeler M, Meyepa L, MCV and MCH cutoffs for Haemoglobinopathy screenng, Poster
Presentation, HAA, Melbourne 2012,
Butler J, Malan E, et al. Establishing an Anti Xa assay to monitor the activity of Fondaparinux
in patients with Renal Failure. Poster presentation, HAA, Melbourne. 2012,
Butler J, Malan E, et al. Assessing the safety of a standard Enoxaparin dosing regimen in
obese patients with newly diagnosed Venous Thromboembolism, Poster presentation, HAA,
Melbourne. 2012
Butler J, Malan E, et al. The clinical outcomes of patients receiving Dabigitran and their
coagulation profile and renal function in a tertiary referral centre, Poster presentation, HAA,
Melbourne 2012
Biancofiore C, Malan E, Butler J. Evaluation of the Stago STic Expert HIT kit in the diagnosis
of HIT, Poster presentation, HAA, Melbourne. 2012
Butler J, Malan E, et al. A Correlation between the Hemoclot Dabigitran Assay and the
Activated thromboplastin time and Thrombin time in a tertiary referral centre., Poster
presentation, HAA, Melbourne, 2012.
Butler J, Malan E, et al, The effect of dabigatran on the activated partial thromboplastin
time and thrombin time as determined by the hemoclot thrombin inhibitor assay in patient
plasma samples. Poster presentation, ISTH Amsterdam 2013
Rushford K, Massive Transfusion Protocols, , Oral presentation, VIDG, Melbourne. 2013
Butler J, Malan E, et al, The effect of dabigitran on the activated partial thromboplastin
time and thrombin time as determined by the hemoclot thrombin inhibitor assay in patient
plasma samples. Thrombo Haemost 2013. (accepted for publication, in print for September
2013 issue)
Fedele P, Wheeler M, et al. ICT testing for malaria screening in refugee patients, poster
presentation, Pathology Update, 2013
Hapgood G, Butler J, Malan E, et al. The effect of dabigatran on the APTT and TT as
determined by the haemoclot TTI in patient plasma samples. Thrombosis and Haemaostasis,
2013, 110/2, 308-315.
Maclachlan K, Butler J, Malan E, et al, Appropriateness of ATS13 level requests to a
reference laboratory, ? need for pretesting advice, Poster presentation, HAA, 2013
Lee D, Butler J, Malan E, et al, Comparison of Prothrombin reagent sensitivities as an
alternative to the Chromogenic antiXa assay for Rivaroxaban monitoring, Poster
presentation, HAA, 2013
Malan E, et al, Dabigatran, APTT and TT, Poster presentation, ISTH Amsterdam, 2013
Handunetti S, Butler J, Malan E, et al, A case report of Dabigatran in emergency cardiac
surgery, Poster presentation, HAA, 2013
Malan E, Correlation of PT reagent sensitivities and Rivaroxaban, Poster presentation,
Werfen User group, 2013
Wallace J, Thrombotic Thrombocytopenic Purpura - Lab testing, Oral presentation AIMS Vic
HDG 2013,
Parker M, Bombay blood group - case study, Oral presentation AIMS Vic HDG, 2013,
Hoskin E, Malaria case study, Oral presentation AIMS VicHDG, 2013,
Butler J, Antithrombin deficiency - case study, Oral presentation AIMS Vic HDG, 2013,
Rushford J, Immune thrombocytopenia - a case study, Oral presentation, AIMS Vic HDG,
2013,
Fedele P, Wheeler M, et al. ICT testing alone is sufficient to identify asymptomatic refugees
at risk of severe malaria presenting to a single health service in Victoria, Pathology, 2014,
46(6), 551-554
Clifford J et al, The influence of NOAC on routine and specialised coagulation laboratory
testing, FAIMS Dissertation 2014
Parker M, Rushford K et al, The trials and tribulations of acquired Anti-JMH antibodies,
Poster Presentation, HAA, 2014
Lee N, Wheeler M, et al, Assessment of correlation and agreement between PT-derived
fibrinogen and Clauss method in a tertiary hospital, Poster presentation, HAA, 2014
Wheeler M, G6PD deficiency - A case study, Oral presentation, AIMS VicHDG, 2014
Cai H, Raised Haemoglobin, Oral presentation, AIMS VicHDG, 2014 Rushford K, PCH - A case study, Oral presentation, AIMS VicHDG, 2014 Butler J, Protein C deficient child - A case study, Oral presentation, AIMS VicHDG, 2014 Meyepa L, Hb A2 variants, Oral presentation, AIMS VicHDG, 2014 Hotchin S, Blood wastage audit, Oral presentation, AIMS VicHDG, 2014 Qayum S, Malan E, Butler J, The advantages of including Anti-Xa assays into routine lupus anticoagulant screening, Poster presentation HAA, Adelaide, 2015 Malan E, Butler J, et al, Homozygout Protein C deficiency – a case report, Poster presentation, HAA, Adelaide 2015 Cason, J, Malan E, Butler J, et al, Rivaroxaban in refractory HITT – A case report, poster presentation, HAA Adelaide, 2015 Wong J, Meyepa L, et al, Raised HbF as a screening test for silent B-globin gene mutations – a retrospective audit, poster presentation, HAA Adelaide, 2015
Sung P, Platelet dysfunction (BSS) – a case study, Oral presentation, AIMS VicHDG, 2015 Qayum S, Lupus anticoagulant testing, Oral presentation, AIMS VicHDG, 2015 Jaskolowski S, TAMS – A case study, Oral presentation, AIMS VicHDG, 2015 Davidson R, A difficult antibody (H1), Oral presentation, AIMS VicHDG, 2015
Mic
rob
iolo
gy Isolation of dermatophytes (and other fungi) from human nail and skin dust
produced by podiatric medical treatments in Australia. Hainsworth S, Hamblin JF, Vanniasinkam T.
J Am Podiatr Med Assoc. 2015 Mar; 105(2):111-20. doi: 10.7547/0003-0538-105.2.111. PMID:
25815649
Rapid Time to Results and High Sensitivity of the CarbaNP Test on Early Cultures.
Lee LY, Korman TM, Graham M. J Clin Microbiol. 2014 Nov;52(11):4023-6. doi:
10.1128/JCM.01682-14. Epub 2014 Aug 20. PMID: 25143572 [PubMed - in process]
Human wound infection with Mannheimia glucosida following lamb bite.
Lau JS, Omeleki L, Turni C, Barber SR, Browning GF, Francis MJ, Graham M, Korman TM. J Clin
Microbiol. 2015 Jul 22. pii: JCM.01249-15. [Epub ahead of print] PMID: 26202121
Local acquisition and nosocomial transmission of Klebsiella pneumoniae harbouring the blaNDM-1
gene in Australia. Tai A, Stuart RL, Sidjabat H, Lemoh C, Rogers BA, Graham M, Paterson DL,
Korman TM. Med J Aust 2015 Mar 16;202(5):270-1.
Acanthamoeba encephalitis: isolation of genotype 1 in mycobacterial liquid culture media. Azzam
R, Francis MJ, Fernandez C, Badenoch P, Adamson P, Dendle C, Woolley IJ, Robson J, Korman TM,
Graham M J Clin Microbiol. 2014 Dec 10. pii: JCM.02887-14. [Epub ahead of print] PMID:
25502534 [PubMed - as supplied by publisher]
Evaluation of the Sofia Influenza A & B, Respiratory Syncytial Virus and Legionella Fluorescent Immunoassays on the Sofia Analyser Megan Wieringa- Monash Medical Centre, VIC Primary Diagnosis of Disseminated Coccidioidomycosis in a Skin Nodule from a Returned Traveller M.J.Francis*, K.Lim, M.Graham, M.Khuu, J.F.Hamblin and T.M.Korman 19th ISHAM Congress, 4-8 May 2015 Melbourne Convention and Exhibition Centre